Skip to search.
 TSX Down 0.13% TSX Ventures Up 0.28%

Osiris Therapeutics, Inc. (OSIR)

-NasdaqGM
5.67 Up 0.08(1.43%) May 27, 4:00PM EDT
Prev Close:5.59
Open:5.63
Bid:4.85 x 900
Ask:5.40 x 300
1y Target Est:8.00
Beta:0.114623
Next Earnings Date:N/A
Day's Range:5.49 - 5.75
52wk Range:3.55 - 23.67
Volume:74,051
Avg Vol (3m):226,172
Market Cap:195.35M
P/E (ttm):135.00
EPS (ttm):0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OSIRUp 1.43%195.35M
UCBJYUp 0.45%13.55B
BIIBUp 0.28%61.95B
ABTUp 1.05%57.74B

Key Statistics

Forward P/E (1 yr):43.62
P/S (ttm):2.22
Ex-Dividend Date:14-Oct-15

Analysts

Annual EPS Est (Dec-15) :0.08
Quarterly EPS Est (Dec-15) :0.06
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Osiris Therapeutics, Inc. researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix, a cryopreserved placental membrane for treating hard-to-treat acute and chroni... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback